Redeye Investor Forum Online
2021-05-20 13:00 - 14:00 (Europe/Stockholm) | Virtual
CEO Ellen Donnelly will present the company at 1:20 p.m. CEST.

UMDF Mitochondrial Medicine
2021-06-24 - 2021-06-26 | Virtual
The US patient organization United Mitochondrial Disease Foundation (UMDF) is hosting its annual Mitochondrial Medicine Symposium, this year virtual, in June.
Abliva will participate in the scientific sessions:

Chief Medical Officer, Magnus Hansson, will constitute one of the panelists, on Friday 25 June, at 1:50 p.m. EST, in the Clinical Trials Panel #2 Discussion, together with representatives from Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion.
Data from Abliva’s Phase 1a/b study with KL1333 will be presented on an e-Poster, available to registered participants throughout the event.

Kvinnokvällen Göteborg
2021-08-31 16:00 - 21:00 | Park Avenue Hotel, Kungsportsavenyn 36-38, Gothenburg, 411 36, Sweden
Abliva will participate at Aktiespararna’s Kvinnokvällen (Women’s night) in Gothenburg, on 31 August 2021.
CEO Ellen Donnelly will be presenting the company digitally, at 6 p.m. CEST.
Follow the event live here: aktiespararna.se/tv/live

Mito-race
2021-09-12 - 2021-09-18 | Virtual
Now you can sign up for LHON Eye Society’s 5 km Mito-race, either in Stockholm on 15 September, or the virtual one on 12 – 18 September. The event takes place in connection to the World Mitochondrial Disease Week (19 – 25 September).

World Mitochondrial Disease Week
2021-09-19 - 2021-09-25 | MA
Every year, during the third week of September, the World Mitochondrial Disease Week (WMDW) is being held. This global, important, and rapidly growing event was an initiative from patient organization International mito-patients (IMP).

Fireside chat
2021-09-28 - 2021-09-29 | MA
Abliva would like to invite interested shareholders and investors to a fun and informal “Fireside Chat” with the company’s CEO, Ellen Donnelly, and members of the Abliva team, in Stockholm (28 September) and Lund (29 September).

After a long stretch of stringent travel restrictions and two-dimensional zoom presentations, we would like to invite Abliva shareholders and interested investors to an informal gathering to hear more about the Abliva strategy and direction directly from Ellen Donnelly (CEO) and the Abliva team. Ellen, an American, joined the company as CEO in February 2021 but has been unable to visit due to COVID restrictions. We hope you will join us in Stockholm or Lund at the end of the month to hear an update on the company and ask your most pressing questions. Seats are limited so please respond quickly to reserve your space.
Stockholm (center): 28 September, 5:00 – 6:00 p.m. CEST.
Lund: 29 September, 4:30 – 5.30 p.m. CEST.
Please respond to anmalan@abliva.com to reserve your space. Meeting details will be provided after registration.

21st Annual Biotech in Europe Forum (BEF) (digital)
2021-10-07 - 2021-10-08 | Basel, Basel, Switzerland
Abliva will attend the digital/hybrid event: 21st Annual Biotech in Europe Forum (BEF), on 7 – 8 October 2021.

Mitochondrial Diseases Conference 2021
2021-10-15 - 2021-10-16 | Virtual
Italian patient organization Mitocon arranges this year’s Mitochondrial Diseases Conference in virtual.
Abliva’s Chief Medical Officer, Magnus Hansson, will give a flash presentation and join round table discussions at the meeting.

Kvinnokvällen (Women's night) Malmö
2021-10-19 | Virtual
Abliva will attend Aktiespararna’s Kvinnokvällen Malmö, on 19 October 2021..
CEO Ellen Donnelly will be presenting the company at 7:30 p.m. CEST.

BioStock Life Science Summit
2021-10-20 - 2021-10-21 | Virtual
Abliva will attend the BioStock Life Science Summit 2021.
CEO Ellen Donnelly will be presenting the company on 20 October at 2:00 p.m. CEST.

Mitochondrial Medicine - Therapeutic Development
2021-11-30 - 2021-12-02 | Virtual
Abliva will attend the virtual conference Mitochondrial Medicine – Therapeutic Development, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK, on 30 Nov – 2 Dec 2021.
Abliva’s CMO, Magnus Hansson, has been invited to give a presentation on the topic Academia-pharma interplay in drug development, during Session 1: Mitochondrial Medicine – pharma and funding perspectives.

Mitochondria-Targeted Drug Development Summit
2022-02-22 - 2022-02-24 | Hyatt Regency Boston/Cambridge, 575 Memorial Dr, Cambridge, Massachusetts, 02139, United States
Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 – 24 February 2022.
CEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease.
Synopsis:

Highlighting the impact of patient input on research and development at Abliva
Providing an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva
Presenting placebo controlled PMD patient data from our lead asset, KL1333

Audiocast with teleconference
2022-06-01 14:00 - 15:00 | Virtual
Abliva invites to a conference call and an online presentation on June 1, 2022, at 14:00 CEST. Abliva’s CEO Ellen Donnelly, CMO Magnus Hansson and CFO Catharina Johansson will inform about the financing and implementation of KL1333 Phase 2/3 study and answer questions. The presentation will be held in English.
After the presentation, there will be a Q&A session. Questions can be asked directly during the teleconference or by sending an email to ir@abliva.com
See link to audiocast below.
Dial-in numbers to conference call:
SE: +46850558355
UK: +443333009274
US: +16467224956

UMDF's Mitochondrial Medicine Symposium
2022-06-08 - 2022-06-11 | JW Marriott Phoenix Desert Ridge Resort & Spa, Phoenix, AZ, United States
Abliva will participate at the United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium in Phoenix, Arizona.
Abliva’s CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion, on Friday June 10.

Fireside Chat in Lund
2022-06-20 16:00 - 18:00 | Restaurang Inspira, Scheeletorget 1, Lund, Sweden
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Lund during the Midsummer week to hear an update on the company, learn more about the ongoing rights issue, and ask your most pressing questions.
The event is free of charge, and wine and snacks will be served. As seats are limited, please respond quickly to reserve your space.
Lund, 20 June, 16:00 – 18:00 p.m. CEST:
Restaurang Inspira, Medicon Village, Scheeletorget 1.
Please respond to anmalan@abliva.com to reserve your space.

Fireside Chat in Stockholm
2022-06-21 16:00 - 18:00 | Erik Penser Bank, Apelbergsgatan 27, Stockholm, Sweden
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Stockholm during the Midsummer week to hear an update on the company, learn more about the ongoing rights issue, and ask your most pressing questions.
The event is free of charge, and wine and snacks will be served. As seats are limited, please respond quickly to reserve your space.
Stockholm, 21 June, 16:00 – 18:00 p.m. CEST:
Erik Penser Bank, Apelbergsgatan 27.
Please respond to anmalan@abliva.com to reserve your space.

Bioblast 2022: Inaugural Conference of Bioenergetics Communications
2022-06-29 - 2022-06-30 | Congress Innsbruck, Rennweg 3, Innsbruck, Austria
On June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria.
Abliva’s Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary of the company’s recent preprint publication “Towards a treatment for mitochondrial disease: current compounds in clinical development“.

Aktiespararna's Digital Temadag - Life Science
2022-08-31 15:00 - 20:40 | Virtual
Abliva will be attending Aktiespararna’s Digital Temadag – Life Science, on Aug 31, 2022.
CEO Ellen Donnelly will present the company at 6:20 p.m. CEST. Follow link below for further information.

mitoNice
2022-09-15 - 2022-09-17 | Nice Acropolis Congress Center, Nice, France
In September, Abliva will attend mitoNice, an international congress dedicated to Mitochondrial Medicine.

Hadean Investor Day
2022-09-21 | Oslo, Norway
More info to come.

Aktiedagen Lund
2022-09-26 | Elite Hotel Ideon, Scheelevägen 27, Lund, 22363, Sweden
On September 26 (Monday), 2022, Abliva will attend Aktiespararna’s Aktiedagen Lund, at Elite Hotel Ideon.
CEO Ellen Donnelly will present the company at 4 p.m. CEST. See below for more info and registration.

Nordic Life Science Days 2022
2022-09-28 - 2022-09-29 | Malmömässan, Mässgatan 6, Malmö, 215 32, Sweden
Abliva will attend the Nordic Life Science Days in Malmö, Sweden, on September 28-29, 2022.
CEO Ellen Donnelly will be presenting the company at 11:00 CEST on Sep 29.

Mitocon's Mitochondrial Diseases Conference
2022-10-07 - 2022-10-08 | Holiday Inn Rome EUR Parco dei Medici, Rome, Italy
In October, Abliva will attend the Italian patient organization Mitocon’s annual Mitochondrial Diseases Conference in Rome, Italy.
On October 8, Abliva’s Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical trials design – presentations and round table discussion.

Shareholders' meeting in Olofström
2022-11-08 18:30 - 20:30 | Olofström, Sweden
Abliva will visit Aktiespararna Västra Blekinge/Bromölla in Olofström on November 8, 2022.
Abliva’s CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening.
See below for more info and registration.

Shareholders' meeting in Tommarp
2022-11-17 18:00 - 20:30 | Tommarps bygdegård, Storgatan 52, Tommarp, Sweden
Abliva will come to Aktiespararna’s local club Sydöstra Skåne, in Tommarp, Sweden, on November 17, 2022.
Abliva’s CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening.
See below for more info and registration.

Mitochondrial Medicine - Therapeutic Development
2022-11-21 - 2022-11-23 | Wellcome Genome Campus, Hinxton, United Kingdom
In late November, Abliva will attend the annual scientific conference Mitochondrial Medicine – Therapeutic Development in Hinxton, UK.
Abliva’s Chief Medical Officer, Magnus Hansson, will present a poster on one of the important preparatory studies for the upcoming, potentially registrational, Phase 2 study, FALCON, with KL1333 in patients with mitochondrial diseases.

Stora Aktiedagen Stockholm
2022-11-28 - 2022-11-30 | Hotel Birger Jarl, Tulegatan 8, Stockholm, Sweden
In late November, Abliva will attend Aktiespararna’s Stora Aktiedagen Stockholm.
The company’s CEO, Ellen Donnelly, will present the company via Zoom on November 29, 2022, at 7:30 p.m. CET.
See below for detailed information and a link to the event.

Nordic American Life Science Conference 2022
2022-12-07 - 2022-12-08 | Shearman & Sterling, 599 Lexington Ave, New York, NY, United States
In December 2022, Abliva will attend the 7th Annual Nordic American Life Science Conference, hosted by DNB, Nasdaq, and Business Sweden, in New York, US.
Abliva’s CEO Ellen Donnelly will present the company on December 8.

BioStock Investor Meeting
2023-03-16 | MA
Abliva will attend the virtual BioStock Investor Meeting on March 16, 2023.
CEO Ellen Donnelly will be presenting the company in BioStock’s studio in Lund. The event will be broadcasted online on the BioStock website and YouTube channel.

BIO-Europe Spring Digital
2023-03-20 - 2023-03-22 | Virtual
We will digitally attend this year’s BIO-Europe spring, hosted in Basel, Switzerland, on March 20 – 22, 2023.
This major life science and biotech meeting offers a great opportunity for networking and partnering.
